Advanced Oncotherapy Plc (AVO)

London
17.00
-0.40(-2.30%)
  • Volume:
    242,058
  • Bid/Ask:
    0.00/0.00
  • Day's Range:
    17.00 - 17.00

AVO Overview

Prev. Close
17.4
Day's Range
17-17
Revenue
-
Open
17
52 wk Range
16.5-40
EPS
-0.077
Volume
242,058
Market Cap
90.31M
Dividend (Yield)
N/A
(N/A)
Average Volume (3m)
375,150
P/E Ratio
-
Beta
0.609
1-Year Change
-53.74%
Shares Outstanding
531,231,209
Next Earnings Date
27 Jun 2023
What is your sentiment on Advanced Oncotherapy?
or
Market is currently closed. Voting is open during market hours.

Advanced Oncotherapy Plc News

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy Plc Company Profile

Advanced Oncotherapy plc, together with its subsidiaries, engages in the designing, assembling, and selling proton-based radiotherapy systems for treatment of cancer. It is developing Linac Image Guided Hadron Technology, a proton therapy system for treating cancer. The company also engages in the management of healthcare related properties. It has operations in the United Kingdom, Switzerland, and the United States. The company was formerly known as CareCapital Group plc and changed its name to Advanced Oncotherapy PLC in September 2012. Advanced Oncotherapy plc was founded in 1994 and is headquartered in London, the United Kingdom.

Read More

Analyst Price Target

Average166.00 (+876.47% Upside)
High166
Low166
Price17
No. of Analysts1
Strong Sell
Sell
Neutral
Buy
Strong Buy
Buy
Analysts 12-Month Price Target

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesSellSellSellStrong SellStrong Sell
Technical IndicatorsSellSellStrong SellStrong SellStrong Sell
SummarySellSellStrong SellStrong SellStrong Sell